Investment Rating - The report gives a "Buy" rating for the company, with a forecasted revenue of 1.791 billion, 2.074 billion, and 2.274 billion yuan for 2025, 2026, and 2027 respectively, and a net profit of 451 million, 524 million, and 576 million yuan for the same years [3]. Core Insights - The company has established a strong position in the medical dressing market through 30 years of development, focusing on high-quality growth and transformation [2][7]. - The company has built a comprehensive product matrix and sales channels, leveraging its first-mover advantage in the professional repair sector [2][3]. - The outlook for the company is positive, with expectations for long-term high-quality growth driven by product expansion and channel optimization [3]. Company Overview - Founded in 1996 as Huaxin Pharmaceutical, the company transitioned to skincare products in 2012 and established itself as a leading player in the medical beauty skincare sector [7][10]. - The company has undergone significant changes, including the establishment of a Shanghai R&D center and a Hangzhou operational subsidiary, to enhance its development towards high-quality growth [3][14]. - The management team, led by founder Zhang Liguo, has extensive experience in the pharmaceutical and skincare industries, ensuring strategic continuity and effective execution of growth plans [14][16]. Industry Overview - The professional skincare market is rapidly expanding, with the medical dressing segment expected to grow significantly due to increasing consumer awareness and demand for effective skincare solutions [42][44]. - The medical dressing market is projected to reach 253.8 billion yuan by 2026, with a growth rate of 22.08%, driven by the rising demand for post-surgical and skin repair products [44][45]. - The market for patch-type products is also expected to grow, with a forecasted size of 271.8 billion yuan by 2026, reflecting a 17.05% growth rate [44][46].

Industry Environment - Fermented skincare is emerging as a new trend in the beauty industry, utilizing microbial technology to convert natural ingredients into effective active components, with a projected market size of 15 billion yuan by 2030 and an annual growth rate of 15% [2] - The 2025 Douyin E-commerce Skincare Trend White Paper reveals four major trends: technological skincare, medical beauty scenarios, targeted care, and emotional skincare, indicating a shift towards scientific and refined consumer demands [3] - The global perfume market is expected to grow from $53 billion in 2025 to $77.53 billion by 2032, with luxury brands like Chanel and Kering's beauty business performing well amid market challenges [4] - The medical beauty sector is becoming a new hotspot in the beauty consumption market, with the Chinese medical beauty market projected to reach 350 to 400 billion yuan by 2025, driven by the Z generation [5] - Small and niche brands are gaining traction in the global beauty market, appealing to younger consumers who prioritize brand values and cultural resonance [6] - In the first half of 2025, the global beauty market saw 61 investment events, with a focus on skincare and personal care sectors, highlighting a significant interest in upstream technologies [7] Company Dynamics - Huaxizi has appointed Wang Junkai as its first global color makeup ambassador in an attempt to revive declining sales, which have seen a 21.19% year-on-year drop in online GMV for 2024 [9] - Estée Lauder's high-end hair care brand Aveda has opened its first flagship store in China, emphasizing a holistic approach to beauty that integrates natural wisdom and immersive experiences [10] - ColorWow, a professional hair care brand, was recently acquired by L'Oréal for $1 billion, showcasing the success of its founder Gail Federici in the hair care industry [11] - Onitsuka Tiger has launched a new perfume line, marking its entry into the beauty sector and aligning with its high-end, fashion-forward strategy [12] - Plant Doctor has been accepted for IPO, focusing on high-altitude plant products, but faces challenges in growth and online transformation [13] - A hair oil brand has topped Douyin's sales charts, driven by increased demand for hair care products among university students during the summer [14] - JD Health has opened its first offline medical beauty clinic in Beijing, aiming to leverage its supply chain advantages in a competitive market [15] - Unilever is focusing on high-end beauty and growth categories as part of its "tail-cutting survival" strategy, with a 1.9% global revenue increase projected for 2024 [17]

Company Overview - Minsheng Health has a diverse business structure, including vitamin and mineral supplements, probiotics, and medical beauty products [1] - The company has established a full industrial chain in the probiotics sector, enhancing its competitive advantage [2][3] Growth in Core Products - The main product, 21 Jinweita® Multivitamin Tablets, has seen a steady increase in market share [2] - Online sales have expanded significantly through three dedicated online business units, contributing to overall revenue growth [2] Probiotics Market Strategy - The company has developed a comprehensive probiotics ecosystem, including over 6,500 strains in its proprietary "Yanhuang Strain Library" [3] - Focus on functional strains and unique technologies to differentiate products in the probiotics market [3] New Product Launches - Minoxidil solution is set to launch in August 2025, while Varenicline tablets are planned for September 2025 [4] - Different marketing strategies will be employed for each product, with a focus on consumer health education for Varenicline [4] Challenges and Solutions - The decline in foot traffic at offline pharmacies poses a challenge; however, the company has built strong relationships with pharmacies to mitigate this [5] - The new skincare brand, Jisuran, aims to convert low-frequency pharmaceutical purchases into higher-frequency skincare sales [5] Organizational Structure - Each business segment operates independently, with dedicated departments for OTC, online retail, and medical beauty [6] - The company emphasizes talent retention and management efficiency to ensure sustainable growth [6] Long-term Strategic Goals - Maintain steady growth in the core vitamin and mineral supplement business [6] - Position the probiotics segment as a second growth curve to catch up with industry leaders [6]